Inscripta
Inscripta is a gene editing technology company developing scalable digital genome engineering based on CRISPR approaches. It offers MADzymes enzymes for precision editing and is building a benchtop platform comprising an instrument, consumables, software, and assays that enables automated, massively parallel, trackable editing of single cells. The platform aims to lower technical and licensing barriers, delivering push-button workflows and low-cost libraries of thousands of designer proteins, pathways, or genome variants, each with defined and trackable mutations. The company also pursues collaboration by making its MAD7 nuclease available free for research and development to broaden access and accelerate biological discovery.
Top Stages
3 past transactions
Sestina Bio
Acquisition in 2023
Founded in 2020, Sestina Bio is a biotechnology company dedicated to developing innovative synthetic biology platforms. The company aims to tackle global challenges by integrating advanced technologies such as synthetic biology, data sciences, and bio-analytical systems.
Infinome Biosciences
Acquisition in 2023
Infinome Biosciences is a pioneering synthetic biology company focused on bioengineering solutions. The company has developed a platform that aims to unlock the vast potential of the genome, facilitating the optimization of commercial biomanufacturing systems. By streamlining these processes, Infinome enables faster and more cost-effective development of new biobased manufacturing methods. This innovation enhances researchers' ability to create robust and efficient solutions for optimizing industrial enzyme performance, ultimately accelerating advancements in the field of biotechnology.
Solana Biosciences
Acquisition in 2018
Solana Biosciences is a life sciences company focused on providing innovative solutions in the field of biotechnology. The firm specializes in sales leads and sales intelligence data, facilitating the launch and production of a diverse array of products. Notably, it has developed a market-leading DNA sequencing service, positioning itself as a key player in the life sciences sector. Through its expertise, Solana Biosciences aims to advance research and development in biotechnology, supporting scientific progress and enhancing product offerings in the industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.